A phase I study of monohydroxyethylrutoside in healthy volunteers.
Willems AM, Bruynzeel AM, Kedde MA, van Groeningen CJ, Bast A, van der Vijgh WJ.
Willems AM, et al. Among authors: van groeningen cj, van der vijgh wj.
Cancer Chemother Pharmacol. 2006 May;57(5):678-84. doi: 10.1007/s00280-005-0083-7. Epub 2005 Sep 1.
Cancer Chemother Pharmacol. 2006.
PMID: 16136309
Clinical Trial.